Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations (Parenthetical)

v3.24.1
Consolidated Statements of Operations (Parenthetical) - Officers, Employees and Directors [Member] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Research and Development Expense [Member]    
Share-based payment arrangement, expense $ 0 $ 718
Selling, General and Administrative Expenses [Member]    
Share-based payment arrangement, expense $ 2,200 $ 3,903